• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃免疫素可产生中和酰胺化和甘氨酸延伸型胃泌素-17的抗体,并抑制结肠癌的生长。

Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer.

作者信息

Watson S A, Michaeli D, Grimes S, Morris T M, Robinson G, Varro A, Justin T A, Hardcastle J D

机构信息

Department of Surgery, Queen's Medical Centre, University of Nottingham, United Kingdom.

出版信息

Cancer Res. 1996 Feb 15;56(4):880-5.

PMID:8631028
Abstract

The effect of gastrin neutralization was evaluated on the in vivo growth of the rat colon line, DHDK12, which expressed cholecystokinin B/gastrin receptors and secreted glycine-extended gastrin-17 (G17). Gastrin neutralization was achieved by administration of the immunogen, Gastrimmune, which is composed of the amino terminal portion of G17 linked to a diphtheria toxoid. A rat-specific version of Gastrimmune was used to preimmunize rats, with control animals receiving diphtheria toxoid only. The antibodies raised neutralized both carboxy-amidated and glycine-extended G17. The tumor was implanted into the muscle layer of the abdominal wall, and rats immunized with Gastrimmune had significantly reduced median cross-sectional tumor areas (70.2% reduction; P = 0.005) and weights (56.5% reduction; P = 0.0078)) when compared to control rats. Histological analysis revealed that the tumors had an enhanced degree of necrosis, with the area of viable tumor in the Gastrimmune-immunized rat reduced to 40.3% compared to 58.6% in the control rats (P = 0.003). Immunization with Gastrimmune raised antibodies that inhibited the growth of a rat colon tumor. This could have been mediated by neutralization of both serum G17 and cell-associated precursor gastrin molecules.

摘要

评估了胃泌素中和对大鼠结肠细胞系DHDK12体内生长的影响,该细胞系表达胆囊收缩素B/胃泌素受体并分泌甘氨酸延伸型胃泌素-17(G17)。通过给予免疫原Gastrimmune实现胃泌素中和,Gastrimmune由与白喉类毒素连接的G17氨基末端部分组成。使用大鼠特异性版本的Gastrimmune对大鼠进行预免疫,对照动物仅接受白喉类毒素。产生的抗体可中和羧基酰胺化和甘氨酸延伸型G17。将肿瘤植入腹壁肌肉层,与对照大鼠相比,用Gastrimmune免疫的大鼠的肿瘤中位横截面积显著减小(减少70.2%;P = 0.005),重量也显著减轻(减少56.5%;P = 0.0078)。组织学分析显示,肿瘤坏死程度增强,Gastrimmune免疫大鼠的存活肿瘤面积降至40.3%,而对照大鼠为58.6%(P = 0.003)。用Gastrimmune免疫可产生抑制大鼠结肠肿瘤生长的抗体。这可能是通过中和血清G17和细胞相关的前体胃泌素分子介导的。

相似文献

1
Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer.胃免疫素可产生中和酰胺化和甘氨酸延伸型胃泌素-17的抗体,并抑制结肠癌的生长。
Cancer Res. 1996 Feb 15;56(4):880-5.
2
Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV.胃免疫产生的抗体可抑制人类结肠肿瘤AP5LV的自发转移。
Eur J Cancer. 1999 Aug;35(8):1286-91. doi: 10.1016/s0959-8049(99)00115-x.
3
Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer.抗胃泌素免疫原G17-DT用于晚期结直肠癌的I/II期研究。
Clin Cancer Res. 2000 Dec;6(12):4719-24.
4
Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5.由胃免疫产生的抗胃泌素抗体可抑制人结肠肿瘤AP5的生长。
Int J Cancer. 1995 Apr 10;61(2):233-40. doi: 10.1002/ijc.2910610216.
5
Pre-clinical evaluation of the Gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model.在大鼠结直肠癌模型中对单独使用及与5-氟尿嘧啶/亚叶酸联合使用的Gastrimmune免疫原进行临床前评估。
Int J Cancer. 1998 Mar 16;75(6):873-7. doi: 10.1002/(sici)1097-0215(19980316)75:6<873::aid-ijc9>3.0.co;2-s.
6
Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor.针对胆囊收缩素B/胃泌素受体的一个表位产生的抗血清可抑制人结肠肿瘤的肝转移。
Cancer Res. 2000 Oct 15;60(20):5902-7.
7
Gastrimmune-induced antigastrin-17 antibodies inhibit acid secretion in a rat fistula model.胃免疫诱导的抗胃泌素-17抗体在大鼠瘘管模型中抑制胃酸分泌。
Aliment Pharmacol Ther. 2001 Dec;15(12):1981-8. doi: 10.1046/j.1365-2036.2001.01081.x.
8
Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.高胃泌素血症促进家族性腺瘤性息肉病APC(Min-/+)小鼠模型中的腺瘤进展。
Cancer Res. 2001 Jan 15;61(2):625-31.
9
[Gastrin-17 and G17-gly induce proliferation of LoVo cells through the CCK B/gastrin receptor].[胃泌素-17和G17-甘氨酸通过CCK B/胃泌素受体诱导LoVo细胞增殖]
Gastroenterol Clin Biol. 1998 Jun-Jul;22(6-7):607-12.
10
A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.两种人类胃癌模型中胃泌素中和治疗效果的比较:与内分泌及自分泌/旁分泌胃泌素介导的生长的关系
Gut. 1999 Dec;45(6):812-7. doi: 10.1136/gut.45.6.812.

引用本文的文献

1
Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer.胰腺癌的癌症疫苗接种及基于免疫的治疗方法
Cancers (Basel). 2025 Jul 15;17(14):2356. doi: 10.3390/cancers17142356.
2
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.单独使用胃泌素疫苗以及与免疫检查点抗体联合使用可抑制胃癌的生长和转移。
Front Oncol. 2021 Dec 1;11:788875. doi: 10.3389/fonc.2021.788875. eCollection 2021.
3
Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes.
胃泌素、胆囊收缩素、信号传导及细胞过程中的生物学活性
Front Endocrinol (Lausanne). 2020 Mar 6;11:112. doi: 10.3389/fendo.2020.00112. eCollection 2020.
4
Use of immunotherapy in the treatment of gastric cancer.免疫疗法在胃癌治疗中的应用。
Oncol Lett. 2019 Dec;18(6):5681-5690. doi: 10.3892/ol.2019.10935. Epub 2019 Sep 30.
5
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.胃泌素疫苗通过改变肿瘤微环境改善了免疫检查点抗体在小鼠胰腺癌中的反应。
Cancer Immunol Immunother. 2019 Oct;68(10):1635-1648. doi: 10.1007/s00262-019-02398-6. Epub 2019 Sep 24.
6
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.胃泌素疫苗,一种多克隆抗体刺激剂,可减少胰腺癌转移。
Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G682-G693. doi: 10.1152/ajpgi.00145.2019. Epub 2019 Aug 21.
7
Low serum gastrin associated with ER breast cancer development via inactivation of CCKBR/ERK/P65 signaling.低血清胃泌素通过 CCKBR/ERK/P65 信号通路失活与 ER 阳性乳腺癌的发生相关。
BMC Cancer. 2018 Aug 16;18(1):824. doi: 10.1186/s12885-018-4717-7.
8
Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.强效胆囊收缩素B受体拮抗剂的鉴定:合成、分子模拟及对胰腺癌细胞的抗癌活性
Medchemcomm. 2017 Jun 14;8(7):1561-1574. doi: 10.1039/c7md00171a. eCollection 2017 Jul 1.
9
Gastrin and Gastric Cancer.胃泌素与胃癌
Cell Mol Gastroenterol Hepatol. 2017 Mar 14;4(1):75-83. doi: 10.1016/j.jcmgh.2017.03.004. eCollection 2017 Jul.
10
The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies.胃泌素和胆囊收缩素受体在胰腺癌及其他恶性肿瘤中的作用
Int J Biol Sci. 2016 Jan 28;12(3):283-91. doi: 10.7150/ijbs.14952. eCollection 2016.